{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:34:43Z","timestamp":1787967283945,"version":"build-2784847793"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,22]]},"DOI":"10.7759\/cureus.19809","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T14:06:35Z","timestamp":1637589995000},"source":"Crossref","is-referenced-by-count":6,"title":["COVID-19-Induced Guillain-Barr\u00e9 Syndrome"],"prefix":"10.7759","author":[{"given":"Joseph E","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia M","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin  C","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid  A","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674922","article-title":"SARS-CoV-2 infection and Guillain-Barr\u00e9 syndrome: a review on potential pathogenic mechanisms","volume":"12","author":"Shoraka S","year":"2021","unstructured":"Shoraka S, Ferreira MLB, Mohebbi SR, Ghaemi A. SARS-CoV-2 infection and Guillain-Barr\u00e9 syndrome: a review on potential pathogenic mechanisms. Front Immunol. 2021, 12:674922. 10.3389\/fimmu.2021.674922","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12339","article-title":"History of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Kusunoki S","year":"2016","unstructured":"Kusunoki S. History of Guillain-Barr\u00e9 syndrome. Clin Exp Neuroimmunol. 2016, 7:305-311. 10.1111\/cen3.12339","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-683. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880120602","article-title":"Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features","volume":"12","author":"Albers JW","year":"1989","unstructured":"Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989, 12:435-51. 10.1002\/mus.880120602","journal-title":"Muscle Nerve"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh S","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021, 268:1133-70. 10.1007\/s00415-020-10124-x","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese G","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020, 25:731-5. 10.1007\/s12192-020-01145-6","journal-title":"Cell Stress Chaperones"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2013.03.023","article-title":"Peripheral neuropathy: clinical and electrophysiological considerations","volume":"24","author":"Chung T","year":"2014","unstructured":"Chung T, Prasad K, Lloyd TE. Peripheral neuropathy: clinical and electrophysiological considerations. Neuroimaging Clin N Am. 2014, 24:49-65. 10.1016\/j.nic.2013.03.023","journal-title":"Neuroimaging Clin N Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Rajabally YA","year":"2012","unstructured":"Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2012, 83:711-8. 10.1136\/jnnp-2011-301882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0826","article-title":"Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barr\u00e9 syndrome: a randomized controlled trial","volume":"43","author":"Khan F","year":"2011","unstructured":"Khan F, Pallant JF, Amatya B, Ng L, Gorelik A, Brand C. Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barr\u00e9 syndrome: a randomized controlled trial. J Rehabil Med. 2011, 43:638-46. 10.2340\/16501977-0826","journal-title":"J Rehabil Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73400-covid-19-induced-guillain-barr-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:11Z","timestamp":1707507011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73400-covid-19-induced-guillain-barr-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.19809","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}